n,n-dimethylarginine has been researched along with Muscular Dystrophy, Duchenne in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckmann, B; Carmann, C; Chobanyan-Jürgens, K; Hörster, I; Kayacelebi, AA; Köhler, C; Lücke, T; Schara, U; Tsikas, D; Weigt-Usinger, K | 1 |
1 trial(s) available for n,n-dimethylarginine and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
The L-arginine/NO pathway and homoarginine are altered in Duchenne muscular dystrophy and improved by glucocorticoids.
Topics: Adolescent; Adult; Arginine; Child; Child, Preschool; Cross-Sectional Studies; Glucocorticoids; Homoarginine; Humans; Infant; Male; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Nitric Oxide; Pilot Projects | 2015 |